Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma
- PMID: 27694002
- DOI: 10.1016/j.biopha.2016.09.056
Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma
Abstract
miRNAs are involved in substantial biological passways, including tumorigenesis, cancer development and progression. Angiogenesis plays a vital role in the progression of hepatocellular carcinoma (HCC), and VEGF is closely associated with the angiogenesis. However, the molecular mechanism of miRNAs in regulation tumorigenesis of HCC remains to be investigated. In the present research, we confirmed that miR-338-3p was suppressed both in HCC tissues and HCC cell lines. Then the tube formation, transwell and Chorioallantoic membrane (CAM) assay were carried out, such indicated that down-regulation of miR-338-3p can sharply increased, while up-regulation drastically suppressed angiogenesis of HCC cells in vitro. Moreover, MACC1 is predicted to be a target of miR-338-3p and we checked the prediction through luciferase assay. And then, our research showed that negative correlation existed between miR-338-3p and MACC1, β-catenin and VEGF that has been reported participated in cancer behavior in HCC cell lines. Subsequently, our assays illustrated that suppression miR-338-3p can up-regulate MACC1, β-catenin and VEGF expression of HCC cells. In conclusion, our research discovered that miR-338-3p can contribute to HCC angiogenesis by targeting MACC1, β-catenin and VEGF.
Keywords: Angiogenesis; Hepatocellular carcinoma; VEGF; microRNA.
Copyright © 2016. Published by Elsevier Masson SAS.
Similar articles
-
MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.J Exp Clin Cancer Res. 2016 Jun 4;35(1):89. doi: 10.1186/s13046-016-0368-1. J Exp Clin Cancer Res. 2016. PMID: 27259866 Free PMC article.
-
MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.Cell Death Dis. 2017 Mar 30;8(3):e2706. doi: 10.1038/cddis.2017.123. Cell Death Dis. 2017. PMID: 28358369 Free PMC article.
-
Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.Oncotarget. 2015 Nov 10;6(35):38093-106. doi: 10.18632/oncotarget.5642. Oncotarget. 2015. PMID: 26497554 Free PMC article.
-
microRNA involvement in hepatocellular carcinoma.Anticancer Agents Med Chem. 2011 Jul;11(6):500-21. doi: 10.2174/187152011796011037. Anticancer Agents Med Chem. 2011. PMID: 21554203 Review.
-
[Research progress of miRNAs targeting GSK-3β in regulation of hepatocellular carcinoma invasion and metastasis].Nan Fang Yi Ke Da Xue Xue Bao. 2017 Jan 20;37(1):138-140. doi: 10.3969/j.issn.1673-4254.2017.01.26. Nan Fang Yi Ke Da Xue Xue Bao. 2017. PMID: 28109115 Free PMC article. Review. Chinese.
Cited by
-
Angiogenesis-related non-coding RNAs and gastrointestinal cancer.Mol Ther Oncolytics. 2021 May 15;21:220-241. doi: 10.1016/j.omto.2021.04.002. eCollection 2021 Jun 25. Mol Ther Oncolytics. 2021. PMID: 34095461 Free PMC article. Review.
-
Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells.Int J Mol Sci. 2021 Dec 31;23(1):452. doi: 10.3390/ijms23010452. Int J Mol Sci. 2021. PMID: 35008876 Free PMC article. Review.
-
circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.Cell Transplant. 2020 Jan-Dec;29:963689720963948. doi: 10.1177/0963689720963948. Cell Transplant. 2020. Retraction in: Cell Transplant. 2024 Jan-Dec;33:9636897241298459. doi: 10.1177/09636897241298459. PMID: 33028110 Free PMC article. Retracted.
-
The tumor suppressor role of microRNA-338-3p in renal cell carcinoma.Oncol Lett. 2018 Aug;16(2):2195-2200. doi: 10.3892/ol.2018.8914. Epub 2018 Jun 6. Oncol Lett. 2018. PMID: 30008918 Free PMC article.
-
MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways.J Exp Clin Cancer Res. 2019 Dec 16;38(1):494. doi: 10.1186/s13046-019-1494-3. J Exp Clin Cancer Res. 2019. Retraction in: J Exp Clin Cancer Res. 2024 Feb 15;43(1):48. doi: 10.1186/s13046-024-02978-0. PMID: 31842953 Free PMC article. Retracted.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous